NCT04229745|Completed
Clinical Trial of Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) Oxygen in Women Having Planned Caesarean Delivery
THRIVEN90
Loading search results
THRIVEN90
Sponsor study identifier
observational
20
1 country
1
Study Start
October 25, 2018
Actual (reported)Primary Completion
June 23, 2019
Actual (reported)Study Completion
June 23, 2019
Actual (reported)Clinical Trial of Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) Oxygen in Women having Planned Caesarean Delivery. Cohort study investigating the efficacy of THRIVE pre-oxygenation using pre-determined number of vital capacity breaths and comparing the efficacy to face mask pre-oxygenation. Aimed to recruit ASA 1-2 term pregnant women having elective caesarean section.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 23, 2019
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 25, 2018
Actual (reported)June 23, 2019
Actual (reported)June 23, 2019
Actual (reported)November 26, 2019
Actual (reported)January 18, 2020
Actual (reported)Number of vital capacity breaths required using THRIVE to pre-oxygenate 90% of parturients to an end tidal oxygen concentration of ≥90% (EN90). End tidal oxygen concentration >= 0.9
measure end tidal oxygen concentration through breathing system attached to anaesthetic machine
8 months study period
EN90 using THRIVE with mouth open versus mouth closed
8 months study period
comfort score of THRIVE
8 months study period
changes in fetal wellbeing during pre-oxygenation time
8 months study period
Clinical Trial of Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) Oxygen in Women having Planned Caesarean Delivery
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
term pregnant women undergoing elective Caesarean section
UCLH
London, NW1 2BU, United Kingdom
20 participants (actual enrollment reported by the registry).
First Submitted
November 26, 2019
First Posted
January 18, 2020
Study Start
October 25, 2018
Actual (reported)Contact the study team to confirm eligibility.
Primary Completion
June 23, 2019
Actual (reported)Study Completion
June 23, 2019
Actual (reported)Last Updated
January 18, 2020
Record last verified: 2020-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: